IP Library Granted Patent US 9,047,503
Granted Patent B2
US 9,047,503 · App. 13/811,399 · Granted Jun 2, 2015

System and method for automated biological cell assay data analysis

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,047,503
App. No.
13/811,399
Granted
Jun 2, 2015
Kind
B2
Abstract

In one aspect, the present invention relates to a system 100 for automated cellular assay data analysis. The system 100 comprises a virtual assay module (VAM) 115 operable to generate simulated images of cell responses to one or more stimuli. The system 100 also comprises a comparator module 116 operable to compare the actual and simulated images, and an analysis module 117 operable to quantify the differences between phenotypes represented by the actual and simulated images. Various aspects and embodiments of present invention may account for stochastic variations in the response of single cells, to provide additional useful information relating to, for example, toxological effects and/or for use as part of a feedback mechanism to refine dynamically a virtual assay model such that it is not limited by way of there being only inadequate static fitting expressions available.

Claims (30)

1. A system for automated cellular assay data analysis, the system comprising:

a virtual assay module (VAM) operable to generate simulated images of cell responses to one or more stimuli, the generated simulated images being created using a stochastic model that simulates a stochastic process wherein behaviour is non-deterministic in that a next system state is determined both by predictable events of the stochastic process and by a random element;

a comparator module operable to compare the actual and simulated images; and

an analysis module operable to quantify the differences between phenotypes represented by the actual and simulated images.

2. The system of claim 1 , wherein the analysis module is further operable to provide feedback to adjust the VAM in accordance with the quantified differences such that the phenotypes of the actual and simulated images converge.

3. The system of claim 1 , wherein the analysis module is further operable to quantify temporally the differences between the phenotypes represented by the actual and simulated images.

4. The system of claim 1 , wherein the analysis module is further operable to apply stochastical fitting to quantify one or more response properties of a single cell's response to said one or more stimuli.

5. The system of claim 1 , wherein

the analysis module is further operable to apply phenomenological response fitting for a high-throughput screening (HTS) analysis.

6. The system of claim 1 , wherein the analysis module is further operable to analyse heterogeneity of a multiple cellular system in response to said one or more stimuli to determine a heterogeneity measurement parameter.

7. The system of claim 1 , wherein phenotypes are toxological phenotypes and the quantified differences are indicative of stimuli toxicity.

8. A method for automated biological cell assay data analysis, the method comprising:

acquiring one or more actual cell images;

creating one or more virtual assay model images using a stochastic model that simulates a stochastic process wherein behaviour is non-deterministic in that a next system state is determined both by predictable events of the stochastic process and by a random element;

comparing at least one of the actual cell images to at least one of the virtual assay model images; and

quantifying any differences identified by comparing actual and virtual assay model images to provide at least one difference parameter.

9. The method of claim 8 , further comprising:

modifying a virtual image model in dependence upon said at least one difference parameter; and

recreating said one or more virtual assay model images using said modified virtual image model.

10. The method of claim 8 , further comprising:

iteratively providing feedback to adjust the virtual assay model so as to minimise the values of said at least one difference parameter in order that the phenotypes of the actual and virtual assay model images converge.

11. The method of claim 8 , further comprising:

temporally quantifying the differences between the phenotypes represented by the actual and virtual assay model images.

12. The method of claim 8 , further comprising:

applying stochastical fitting to quantify one or more response parameters for a single cell's response to one or more stimuli.

13. The method of claim 8 , further comprising:

applying phenomenological response fitting to a high-throughput screening (HTS) analysis.

14. The method of claim 8 , further comprising:

analysing heterogeneity of a multiple cellular system in response to one or more stimuli to determine a heterogeneity measurement parameter.

15. The method of claim 8 , wherein phenotypes are toxological phenotypes and the quantified differences are indicative of stimuli toxicity.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2020
From: GE HEALTHCARE UK LIMITED
To: GLOBAL LIFE SCIENCES SOLUTIONS OPERATIONS UK LTD
Reel/Frame 053653/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 22, 2013
From: ALEXANDROV, YURIY
To: GE HEALTHCARE UK LIMITED
Reel/Frame 029666/0466 →